首页|氨溴特罗口服液联合胸腔体外振荡排痰仪及异丙托溴铵雾化吸入治疗小儿肺炎的临床效果

氨溴特罗口服液联合胸腔体外振荡排痰仪及异丙托溴铵雾化吸入治疗小儿肺炎的临床效果

扫码查看
目的 研究氨溴特罗口服液联合胸腔体外振荡排痰仪及异丙托溴铵雾化吸入治疗小儿肺炎的临床效果.方法 选取 2022 年7 月-2023 年 6 月信丰县人民医院儿科收治的 60 例小儿肺炎患者,经随机数字表法分为对照组(30 例)与治疗组(30 例),对照组给予氨溴特罗口服液与胸腔体外振荡排痰仪治疗,治疗组在其基础上联合异丙托溴铵雾化吸入治疗.比较两组痰液排出时间、肺部湿罗音消失时间、呼吸困难缓解情况(呼吸频率、三凹征比例)、肺部通气情况[血氧饱和度(SaO2)、血氧分压(PaO2)、血二氧化碳分压(PaCO2)]、并发症情况(肺实变、肺不张、低氧血症)、呼吸机使用率及住院时间.结果 治疗组痰液排出时间、肺部湿罗音消失时间短于对照组(P<0.05);两组治疗后呼吸频率、三凹征比例均小于治疗前,且治疗组呼吸频率、三凹征比例小于对照组(P<0.05);两组治疗后SaO2、PaO2 高于治疗前,PaCO2 低于治疗前,且治疗组SaO2、PaO2 高于对照组,PaCO2 低于对照组(P<0.05);治疗组肺实变、肺不张、低氧血症发生率小于对照组(P<0.05);治疗组呼吸机使用率小于对照组,住院时间短于对照组(P<0.05).结论 氨溴特罗、胸腔体外振荡排痰仪与异丙托溴铵雾化吸入治疗小儿肺炎效果确切,可加速痰液排出,缩短患儿肺部湿罗音消失时间,有利于患儿呼吸困难症状的缓解,可改善其肺通气功能,降低肺实变、肺不张、低氧血症的发生风险,减少呼吸机使用率,缩短住院时间.
Clinical Effect of Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution Combined with Chest Wall Oscillation Instrument and Ipratropium Bromide Aerosol Inhalation in the Treatment of Pneumonia in Children
Objective To study the clinical effect of ambroxol hydrochloride and clenbuterol hydrochloride oral solution combined with chest wall oscillation instrument and ipratropium bromide atomization inhalation in the treatment of children with pneumonia.Methods From July 2022 to June 2023,60 children with pneumonia admitted to the Department of Pediatrics,Xinfeng County People's Hospital were selected and divided into control group(30 children)and treatment group(30 children)by random number table method.The control group was treated with ambroxol oral liquid and in vitro oscillation sputum elimination instrument,and the treatment group was treated with ipratropium bromide aerosol inhalation on the basis of the control group.The sputum discharge time,disappearance time of lung moist rales,remission of dyspnea(respiratory rate,proportion of three concave signs),pulmonary ventilation[blood oxygen saturation(SaO2),blood oxygen partial pressure(PaO2),blood carbon dioxide partial pressure(PaCO2)],complications(pulmonary consolidation,atelectasis,hypoxemia),ventilator utilization rate and hospitalization time were compared between the two groups.Results The sputum discharge time and lung moist rale disappearance time in the treatment group were shorter than those in the control group(P<0.05).After treatment,the respiratory rate and the proportion of three-concave sign in the two groups were lower than those before treatment,and the respiratory rate and the proportion of three-concave sign in the treatment group were lower than those in the control group(P<0.05).After treatment,SaO2 and PaO2 in the two groups were higher than those before treatment,PaCO2 was lower than that before treatment,and SaO2 and PaO2 in the treatment group were higher than those in the control group,PaCO2 was lower than that in the control group(P<0.05).The incidence of pulmonary consolidation,atelectasis and hypoxemia in the treatment group was lower than that in the control group(P<0.05).The ventilator utilization rate in the treatment group was lower than that in the control group,and the hospitalization time was shorter than that in the control group(P<0.05).Conclusion The effect of ambroxol hydrochloride and clenbuterol hydrochloride oral solution combined with chest wall oscillation instrument and ipratropium bromide atomization inhalation in the treatment of children with pneumonia is definite,which can accelerate sputum discharge,shorten the disappearance time of lung wet rales in children,and is beneficial to the relief of dyspnea symptoms in children.Meanwhile,it can improve the pulmonary ventilation function,reduce the risk of pulmonary consolidation,atelectasis and hypoxemia,reduce the utilization rate of ventilator and shorten the hospitalization time.

Pneumonia in childrenAmbroxol hydrochloride and clenbuterol hydrochlorideChest wall oscillation instrumentIpratropium bromideRespiratoryrateThree-concave sign

黄红梅、谢家洪、郭金秀

展开 >

信丰县人民医院儿科,江西 信丰 341600

小儿肺炎 氨溴特罗 胸腔体外振荡排痰仪 异丙托溴铵 呼吸频率 三凹征

2024

医学信息
国家卫生部信息化管理领导小组 中国电子学会中国医药信息学分会 陕西文博生物信息工程研究所

医学信息

影响因子:0.161
ISSN:1006-1959
年,卷(期):2024.37(19)